Digest Network Come funziona
Network
/
Società
Cl
Non verificato

ClearNote Health

Di cosa scriviamo

BiotecnologiaIndustriaMedicina - VarieOncologiaSalute

19 comunicati stampa

Guarda tutti i comunicati
16/09/2026
Scienza
Biotecnologia
Medicina - Varie
Medicina nucleare
Salute
Oncologia
Eventi
Fiere
ClearNote Health to Showcase Power of 5hmC Signatures for Treatment Monitoring at AACR Conference on Pancreatic Cancer
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
09/07/2026
Mercato del lavoro
Biotecnologia
Sanità
Salute
Farmaceutica
ClearNote Health Announces Leadership Transition
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
27/05/2026
Mercato del lavoro
Eventi
Fiere
Associazioni/Professionisti
Oncologia
Salute
Finanza
Biotecnologia
ClearNote Health Secures $52 Million in Series D Financing and Strengthens Leadership Team to Accelerate Growth in Early Cancer Detection
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
22/05/2026
Eventi
Industria
Biotecnologia
Salute
Oncologia
ClearNote Health to Present Early Detection Validation Data for Avantect® Pancreatic Cancer Test at 2026 ASCO Annual Meeting
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
29/04/2026
Eventi
Industria
Scienza
Attrezzature medico-sanitarie
Medicina - Varie
Salute
Farmaceutica
Sanità
Oncologia
ClearNote Health to Present Industry-Leading Early Detection Data for Avantect® Pancreatic Cancer Test at Digestive Disease Week 2026
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
15/04/2026
Scienza
Attrezzature medico-sanitarie
Medicina - Varie
Salute
Farmaceutica
Sanità
Oncologia
ClearNote Health to Showcase Industry-Leading Early Detection Performance of the Avantect® Pancreatic Cancer Test at AACR Annual Meeting 2026
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
18/03/2026
Sanità
Salute
Scienza
Mercato del lavoro
ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
23/02/2026
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
ClearNote Health’s Enhanced Avantect® Pancreatic Cancer Test Delivers Industry-Leading Early Detection Performance
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
17/10/2025
Scienza
Oncologia
Tecnica
Attrezzature medico-sanitarie
Biotecnologia
Medicina - Varie
Cardiologia
Salute
Eventi
ClearNote Health to Showcase Latest Advancements in Early Cancer Detection Testing at ESMO Congress 2025
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
25/09/2025
Industria
Biotecnologia
Sanità
Attrezzature medico-sanitarie
Salute
Oncologia
ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0